The Effect of Oral Probiotics on Glycemic Control of Women With

Status Completed

Clinical Trial Summary

Scientific background: Uncontrolled gestational diabetes mellitus (GDM) is associated with severe maternal and neonatal morbidities. Treatment of GDM is multidisciplinary and includes lifestyle changes and medications. However, the efficacy of these treatments is limited due to poor motivation, daily painful blood tests and multiple injections. Probiotic supplements were shown to modulate the gut microbiome by reducing the adverse metabolic effects associated with pathogenic microbial colonization. Promising effects on glycemic control and insulin resistance in non-pregnant diabetic patients were reported. However, the effect of probiotics on glycemic control in GDM has not been elucidated. Objectives: To examine the effect of a mixture of probiotic strains given daily on maternal glycemic parameters, and pregnancy outcomes among women with GDM. Working hypothesis: Oral administration of probiotics will be effective in glucose control of patients with GDM and their neonates without causing significant adverse effects. Type of research and methods of data collection: A prospective randomized, double blind, placebo controlled trial. Women newly diagnosed with GDM will be recruited and followed in the GDM clinic and Maternal-Fetal Medicine ward (including the research clinic) at Emek Medical Center. They will be divided into a research group, receiving the probiotic formula Femina II and a control group, receiving a placebo (2 capsules/day) until delivery. Glycemic control will be evaluated by daily glucose charts. After 2 weeks of diet and probiotic/placebo treatment and thereafter, pharmacotherapy will be started in case of poor glycemic control according to the daily glucose charts. Blood tests for glycated molecules will be performed. Fetal well-being and growth will be assessed. The primary outcomes are: 1. The rate of women requiring medications for glycemic control 2. Mean value of the mean daily glucose charts after 2 weeks of treatment with the study products.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03864549
Study type	Interventional
Source	HaEmek Medical Center, Israel
Contact
Status	Completed
Phase	N/A
Start date	January 8, 2020
Completion date	August 1, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06099574` - A Study on the Oral Health Status of Pregnant Women With Gestational Diabetes and Its Correlation With Oral Flora
Completed	`NCT02890693` - Improving Cardio-metabolic and Mental Health in Women With Gestational Diabetes Mellitus and Their Offspring	N/A
Completed	`NCT02744300` - Balance After Baby Intervention for Women With Recent Gestational Diabetes	N/A
Completed	`NCT02436551` - Gestational Diabetes in Central Asia: Prevalence and Management
Completed	`NCT02384226` - User Testing and Feedback for a Mobile Health Program for Postpartum Women: A Pilot Study
Recruiting	`NCT02275845` - Medico-GDM Trial - Metformine to Prevent Gestational Diabetes Mellitus	Phase 3
Recruiting	`NCT04621396` - The Next Generation Longitudinal Birth Cohort Diabetes Study
Completed	`NCT01931280` - A Transgenerational e-Intervention for Gestational Diabetics and Their Offspring	N/A
Completed	`NCT01916694` - Trial of Remote Evaluation and Treatment of Gestational Diabetes Mellitus	N/A
Not yet recruiting	`NCT01637727` - Long Term Effects of Gestational Diabetes Mellitus in a Population of Parous Women	N/A
Completed	`NCT01565564` - Randomized Translational Study to Examine the Effects of Shared Care in Management of Gestational Diabetes	N/A
Recruiting	`NCT00550979` - Gestational Diabetes Mellitus and Implications for Cardiovascular Disease Risk	N/A
Completed	`NCT00460018` - Diet, Exercise, and Breastfeeding Intervention Program for Women With Gestational Diabetes (DEBI Trial)	Phase 2
Not yet recruiting	`NCT04915716` - Effect of Fasting Time Before Cesarean Section on Neonatal Blood Glucose in Pregnant Women With Gestational Diabetes Mellitus
Completed	`NCT04422821` - Flash Glucose Monitoring in Gestational Diabetes Mellitus: Study Protocol for a Randomized Controlled Trial	N/A
Recruiting	`NCT04369313` - Effect of DCC on Neonatal Jaundice and Blood Gas Analysis in Infants Born to GDM Mothers	N/A
Recruiting	`NCT05348863` - SPARK- a Digital Platform to Improve Self-management of Gestational Diabetes	N/A
Recruiting	`NCT04272840` - The Impact of Glycemic Index Education on Lowering Dietary GI in Gestational Diabetes Mellitus	N/A
Completed	`NCT02588729` - A Mobile Smartphone Application to Promote a Healthy Diet and Physical Activity Among Pregnant Women With GDM - RCT	N/A
Completed	`NCT01922791` - Nutrition and Pregnancy Intervention Study	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

The Effect of Oral Probiotics on Glycemic Control of Women With Gestational Diabetes Mellitus

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms